Cargando…
Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and ECNP.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744705/ https://www.ncbi.nlm.nih.gov/pubmed/36640691 http://dx.doi.org/10.1016/j.euroneuro.2022.12.001 |
_version_ | 1784848980143767552 |
---|---|
author | Boretti, Alberto |
author_facet | Boretti, Alberto |
author_sort | Boretti, Alberto |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9744705 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier B.V. and ECNP. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97447052022-12-13 Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe Boretti, Alberto Eur Neuropsychopharmacol Correspondence Elsevier B.V. and ECNP. 2023-02 2022-12-13 /pmc/articles/PMC9744705/ /pubmed/36640691 http://dx.doi.org/10.1016/j.euroneuro.2022.12.001 Text en © 2022 Elsevier B.V. and ECNP. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Boretti, Alberto Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe |
title | Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe |
title_full | Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe |
title_fullStr | Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe |
title_full_unstemmed | Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe |
title_short | Effectiveness of fluvoxamine at preventing COVID-19 infection from turning severe |
title_sort | effectiveness of fluvoxamine at preventing covid-19 infection from turning severe |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744705/ https://www.ncbi.nlm.nih.gov/pubmed/36640691 http://dx.doi.org/10.1016/j.euroneuro.2022.12.001 |
work_keys_str_mv | AT borettialberto effectivenessoffluvoxamineatpreventingcovid19infectionfromturningsevere |